506 related articles for article (PubMed ID: 32344926)
21. Development of a new mouse model for coxsackievirus-induced myocarditis by attenuating coxsackievirus B3 virulence in the pancreas.
Pinkert S; Pryshliak M; Pappritz K; Knoch K; Hazini A; Dieringer B; Schaar K; Dong F; Hinze L; Lin J; Lassner D; Klopfleisch R; Solimena M; Tschöpe C; Kaya Z; El-Shafeey M; Beling A; Kurreck J; Van Linthout S; Klingel K; Fechner H
Cardiovasc Res; 2020 Aug; 116(10):1756-1766. PubMed ID: 31598635
[TBL] [Abstract][Full Text] [Related]
22. Caboxamycin Inhibits Heart Inflammation in a Coxsackievirus B3-Induced Myocarditis Mouse Model.
Kim HG; Hillman PF; Lee YJ; Jeon HE; Lim BK; Nam SJ
Viruses; 2024 Apr; 16(5):. PubMed ID: 38793559
[TBL] [Abstract][Full Text] [Related]
23. Fasudil exerts a cardio-protective effect on mice with coxsackievirus B3-induced acute viral myocarditis.
Dai K; Wang Y; Tai S; Ni H; Lian H; Yu Y; Liao W; Zheng C; Chen Q; Kuver A; Li J
Cardiovasc Ther; 2018 Dec; 36(6):e12477. PubMed ID: 30380183
[TBL] [Abstract][Full Text] [Related]
24. Combination of RNA interference and virus receptor trap exerts additive antiviral activity in coxsackievirus B3-induced myocarditis in mice.
Stein EA; Pinkert S; Becher PM; Geisler A; Zeichhardt H; Klopfleisch R; Poller W; Tschöpe C; Lassner D; Fechner H; Kurreck J
J Infect Dis; 2015 Feb; 211(4):613-22. PubMed ID: 25193982
[TBL] [Abstract][Full Text] [Related]
25. Protective effects of 20(s)-protopanaxtriol on viral myocarditis infected by coxsackievirus B3.
Wang X; Wang Y; Ren Z; Qian C; Li Y; Wang Q; Zhang Y; Zheng L; Jiang J; Yang C; Wang D; Zhang Y; Fan J; Wang Y
Pathobiology; 2012; 79(6):285-9. PubMed ID: 22688124
[TBL] [Abstract][Full Text] [Related]
26. The comparison of α-bromo-4-chlorocinnamaldehyde and cinnamaldehyde on coxsackie virus B3-induced myocarditis and their mechanisms.
Zhang Y; Cao W; Xie YH; Yang Q; Li XQ; Liu XX; Wang SW
Int Immunopharmacol; 2012 Sep; 14(1):107-13. PubMed ID: 22709476
[TBL] [Abstract][Full Text] [Related]
27. ORI2 inhibits coxsackievirus replication and myocardial inflammation in experimental murine myocarditis.
Lim BK; Kim JH
Biol Pharm Bull; 2014; 37(10):1650-4. PubMed ID: 25273388
[TBL] [Abstract][Full Text] [Related]
28. Protective effects of losartan in mice with chronic viral myocarditis induced by coxsackievirus B3.
Zhang YY; Li JN; Xia HH; Zhang SL; Zhong J; Wu YY; Miao SK; Zhou LM
Life Sci; 2013 Jul; 92(24-26):1186-94. PubMed ID: 23702425
[TBL] [Abstract][Full Text] [Related]
29. Histone deacetylase inhibitors suppress coxsackievirus B3 growth in vitro and myocarditis induced in mice.
Shim SH; Park JH; Ye MB; Nam JH
Acta Virol; 2013; 57(4):462-6. PubMed ID: 24294962
[TBL] [Abstract][Full Text] [Related]
30. Cardiac fibroblasts aggravate viral myocarditis: cell specific coxsackievirus B3 replication.
Lindner D; Li J; Savvatis K; Klingel K; Blankenberg S; Tschöpe C; Westermann D
Mediators Inflamm; 2014; 2014():519528. PubMed ID: 25374444
[TBL] [Abstract][Full Text] [Related]
31. Ubiquitin-like protein ISG15 (interferon-stimulated gene of 15 kDa) in host defense against heart failure in a mouse model of virus-induced cardiomyopathy.
Rahnefeld A; Klingel K; Schuermann A; Diny NL; Althof N; Lindner A; Bleienheuft P; Savvatis K; Respondek D; Opitz E; Ketscher L; Sauter M; Seifert U; Tschöpe C; Poller W; Knobeloch KP; Voigt A
Circulation; 2014 Oct; 130(18):1589-600. PubMed ID: 25165091
[TBL] [Abstract][Full Text] [Related]
32. Treatment of coxsackievirus-B3-infected BALB/c mice with the soluble coxsackie adenovirus receptor CAR4/7 aggravates cardiac injury.
Dörner A; Grunert HP; Lindig V; Chandrasekharan K; Fechner H; Knowlton KU; Isik A; Pauschinger M; Zeichhardt H; Schultheiss HP
J Mol Med (Berl); 2006 Oct; 84(10):842-51. PubMed ID: 16924471
[TBL] [Abstract][Full Text] [Related]
33. Effect of prophylactically applied CpG ODN on the development of myocarditis in mice infected with Coxsackievirus B3.
Zhao T; Wu X; Song D; Fang M; Guo S; Zhang P; Wang L; Wang L; Yu Y
Int Immunopharmacol; 2012 Dec; 14(4):665-73. PubMed ID: 23063973
[TBL] [Abstract][Full Text] [Related]
34. Phyllaemblicin B inhibits Coxsackie virus B3 induced apoptosis and myocarditis.
Wang YF; Wang XY; Ren Z; Qian CW; Li YC; Kaio K; Wang QD; Zhang Y; Zheng LY; Jiang JH; Yang CR; Liu Q; Zhang YJ; Wang YF
Antiviral Res; 2009 Nov; 84(2):150-8. PubMed ID: 19699238
[TBL] [Abstract][Full Text] [Related]
35. Antiviral Peptides Targeting the Helicase Activity of Enterovirus Nonstructural Protein 2C.
Fang Y; Wang C; Wang C; Yang R; Bai P; Zhang XY; Kong J; Yin L; Qiu Y; Zhou X
J Virol; 2021 May; 95(12):. PubMed ID: 33789997
[TBL] [Abstract][Full Text] [Related]
36. Protease-activated receptor-2 regulates the innate immune response to viral infection in a coxsackievirus B3-induced myocarditis.
Weithauser A; Bobbert P; Antoniak S; Böhm A; Rauch BH; Klingel K; Savvatis K; Kroemer HK; Tschope C; Stroux A; Zeichhardt H; Poller W; Mackman N; Schultheiss HP; Rauch U
J Am Coll Cardiol; 2013 Nov; 62(19):1737-45. PubMed ID: 23871888
[TBL] [Abstract][Full Text] [Related]
37. Experimental CVB3-induced chronic myocarditis in two murine strains: evidence of interrelationships between virus replication and myocardial damage in persistent cardiac infection.
Andréoletti L; Hober D; Becquart P; Belaich S; Copin MC; Lambert V; Wattré P
J Med Virol; 1997 Jun; 52(2):206-14. PubMed ID: 9179770
[TBL] [Abstract][Full Text] [Related]
38. Antiviral effects of sophoridine against coxsackievirus B3 and its pharmacokinetics in rats.
Zhang Y; Zhu H; Ye G; Huang C; Yang Y; Chen R; Yu Y; Cui X
Life Sci; 2006 Mar; 78(17):1998-2005. PubMed ID: 16309710
[TBL] [Abstract][Full Text] [Related]
39. Pathogenic Role of the Damage-Associated Molecular Patterns S100A8 and S100A9 in Coxsackievirus B3-Induced Myocarditis.
Müller I; Vogl T; Pappritz K; Miteva K; Savvatis K; Rohde D; Most P; Lassner D; Pieske B; Kühl U; Van Linthout S; Tschöpe C
Circ Heart Fail; 2017 Nov; 10(11):. PubMed ID: 29158436
[TBL] [Abstract][Full Text] [Related]
40. Cathelicidins Target HSP60 To Restrict CVB3 Transmission via Disrupting the Exosome and Reducing Cardiomyocyte Apoptosis.
Yang Y; Huang C; Hui L; Song Y; Fu Y; Li M; Yang H; Wu J; Sun J; Xu W; Wei L
J Virol; 2023 Mar; 97(3):e0143322. PubMed ID: 36916989
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]